biotechnology founded 1993 headquarters fort collins co area served united states products bioscience products website www.ventria.com ventria bioscience is a biotech company with a focus on human nutrition and human therapeutics . the company was established in 1993 in colorado . 1 the company s core technology is a genetically modified crop based protein production system also called a pharming system called expresstec . contents 1 regulatory advantages 2 facilities 3 markets and products 4 see also 5 references 6 external links regulatory advantages edit expresstec uses self pollinating crops such as rice and barley to minimize the risk of gene flow normally associated with transgenic plants . plant produced proteins also offer advantages for cell culture and bioprocessing use because they replace animal derived components which have become unpopular due to concerns about prion contamination . facilities edit ventria s corporate headquarters is in fort collins colorado with additional facilities in kansas . on september 29 2006 kansas officials announced an agreement to bring ventria s new bioprocessing facility to junction city kansas . kansas governor kathleen sebelius was very supportive of the agreement and was quoted as stating i welcome ventria bioscience to kansas and look forward to their contributions to the health of children worldwide . 2 the effort to attract ventria to kansas involved a number of players including governor kathleen sebelius secretary of agriculture adrian polansky the kansas department of commerce junction city and geary county kansas technology enterprise corporation ktec kansasbio kansas state university and kansas farm bureau . markets and products edit as of 2012 ventria is developing six therapeutic products human health ven100 recombinant human lactoferrin for antibiotic associated diarrhea 3 ven101 for chemotherapy induced diarrhea 4 ven120 for inflammatory bowel disease 5 ven130 for osteoporosis 6 ven140 for hepatic disease 7 ven200 optibumin recombinant human albumin as a replacement for therapeutic human serum albumin 8 the company offers contract biomanufacturing services using its expresstec platform and through its subsidiary invitria sells a line of its proteins that it manufactures for the life sciences research market . 9 the company is conducting research in the field of zoonotic disease specifically in lyme disease and rabies with a goal of developing vaccines and offers some its recombinant proteins to life sciences researchers under a program called bioshare . 10 in april 2012 ventria publicized 11 results of a phase 2 clinical study of ven100 to reduce incidence of antibiotic associated diarrhea in hospitalized patients conducted by investigators at johns hopkins university which had been published in 2011 . 12 patients treated with ven100 concurrently with antibiotic treatment were at a reduced risk of experiencing diarrhea compared to the participants in the control group and ven100 was also found to be safe and well tolerated with no observed adverse events in the study . previously the results of another study found that an electrolyte solution incorporating ventria s recombinant lactoferrin and lysozyme helped children recover faster from diarrhea . 13 the results showed that the children receiving ventria s product recovered 30 % faster were more likely to recover from their diarrhea and were less likely to relapse into another episode . in march 2012 ventria announced an exclusive collaboration with merck kgaa emd millipore in which ventria will use its expresstec system to manufacture and exclusively supply a recombinant protein to merck emd millipore . 14 see also edit ventria website references edit bloomberg businessweek ventria bioscience inc. http www.kansasbio.org news pdf kansas ventria.pdf ventria ven100 page ventria ven101 page ventria ven120 page ventria ven130 page ventria ven140 information on pipeline page ventria ven200 page invitria official website http www.ventria.com bioshare ventria press release laffan am et al. 2011 lactoferrin for the prevention of post antibiotic diarrhoea . j health popul nutr . 2011 ; 29 6 547 551 1 zavaleta n et al. 2007 efficacy of rice based oral rehydration solution containing recombinant human lactoferrin and lysozyme in peruvian children with acute diarrhea . j pediatr gastroenterol nutr . 44 2 258 64 . 2 ventria press release external links edit ventria bioscience official site v t e pharmaceutical companies of the united states abbott laboratories acorda therapeutics actavis aderis pharmaceuticals adolor corporation alcon alexion pharmaceuticals alkermes allergan alza amgen amylin pharmaceuticals ariad pharmaceuticals aryx therapeutics avax technologies baxter international biocryst pharmaceuticals biogen biolex biovest biovista bradley pharmaceuticals bristol myers squibb cancervax century pharmaceuticals cephalon ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cotherix covance covidien cubist pharmaceuticals cutter laboratories cytosport cytrx danco laboratories dnaprint genomics epix pharmaceuticals eli lilly and company elorac endo pharmaceuticals ethicon endo surgery ethicon inc. forest laboratories galena biopharma genvec genentech genta gilead sciences hospira imclone systems institute for oneworld health intercept pharmaceuticals ista pharmaceuticals ivax corporation janssen biotech johnson & johnson kinetic concepts king pharmaceuticals kinray kv pharmaceutical leiner health products mallinckrodt martek biosciences corporation s. e. massengill company mckesson corporation mcneil laboratories melior discovery mentholatum merck & co. miles laboratories mylan myriad genetics naurex nereus pharmaceuticals northwest biotherapeutics norwich pharma services novabay pharmaceuticals nuvelo organon international ortho pharmaceutical ortho mcneil pharmaceutical osi pharmaceuticals ovation pharmaceuticals par pharmaceutical parke davis perrigo pfizer pharmaceutical product development prasco laboratories procter & gamble proteon therapeutics purdue pharma qualitest quark pharmaceuticals regeneron repros therapeutics rib x pharmaceuticals sarepta therapeutics savage laboratories schering plough g. d. searle & company sheffield pharmaceuticals smith kline & french spectrum pharmaceuticals sterling drug tanox tap pharmaceutical products tec laboratories teva pharmaceutical industries tiens biotech group titan pharmaceuticals trevena inc trubion upjohn upsher smith laboratories valeant pharmaceuticals ventria bioscience vertex pharmaceuticals verus pharmaceuticals vion pharmaceuticals inc. viropharma west pharmaceutical services wyeth zonite products corporation list of pharmaceutical companies retrieved from https en.wikipedia.org w index.php title ventria bioscience & oldid 729831829 categories pharmaceutical companies of the united statesbiotechnology companies of the united statesprivately held companies based in coloradocompanies based in fort collins coloradopharmaceutical companies established in 1993technology companies established in 1993hidden categories pages using infobox company with unsupported parameters navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages add links this page was last modified on 14 july 2016 at 21 20 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view